---

Related Articles:

End-binding proteins sensitize microtubules to the action of microtubule-targeting agents.

2013-05-28

[Proc. Natl. Acad. Sci. U. S. A. 110(22) , 8900-5, (2013)]

The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma.

1995-06-01

[Anticancer Drugs 6(3) , 392-7, (1995)]

Effects of dolastatins on human B-lymphocytic leukemia cell lines.

1993-04-01

[Leuk. Res. 17(4) , 333-9, (1993)]

Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates.

2012-09-01

[Cancer Chemother. Pharmacol. 70(3) , 439-49, (2012)]

Quantitation of dolastatin-10 using HPLC/electrospray ionization mass spectrometry: application in a phase I clinical trial.

1998-01-01

[Cancer Chemother. Pharmacol. 41(4) , 299-306, (1998)]